GE HealthCare Technologies (NASDAQ:GEHC) Updates FY 2026 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) updated its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 4.800-5.000 for the period, compared to the consensus estimate of 4.870. The company issued revenue guidance of -. GE HealthCare Technologies also updated its Q2 2026 guidance to EPS.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of recent research reports. Piper Sandler cut their target price on shares of GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. The Goldman Sachs Group reissued a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Citigroup reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. Wells Fargo & Company lowered their price target on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Finally, BTIG Research restated a “buy” rating and issued a $75.00 price target on shares of GE HealthCare Technologies in a research report on Monday, July 13th. Ten research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Hold” and an average price target of $76.41.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock traded up $0.58 during mid-day trading on Thursday, hitting $61.99. The stock had a trading volume of 4,466,707 shares, compared to its average volume of 4,441,490. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The firm has a market cap of $28.20 billion, a PE ratio of 14.83, a PEG ratio of 1.69 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The company’s 50-day simple moving average is $63.65 and its 200-day simple moving average is $71.46.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The firm had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts anticipate that GE HealthCare Technologies will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.35%.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, Director Rodney F. Hochman purchased 1,618 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were purchased at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the purchase, the director directly owned 1,618 shares in the company, valued at $100,364.54. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO James Saccaro acquired 3,310 shares of the business’s stock in a transaction on Friday, May 1st. The stock was acquired at an average price of $60.60 per share, with a total value of $200,586.00. Following the transaction, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at $5,300,742.60. This represents a 3.93% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders bought 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is owned by company insiders.

Institutional Trading of GE HealthCare Technologies

A number of institutional investors have recently added to or reduced their stakes in GEHC. Transamerica Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $34,000. Zions Bancorporation National Association UT grew its holdings in shares of GE HealthCare Technologies by 125.1% in the 4th quarter. Zions Bancorporation National Association UT now owns 412 shares of the company’s stock worth $34,000 after acquiring an additional 229 shares during the period. Miller Capital Partners Inc. acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter worth approximately $38,000. Finally, Palisade Asset Management LLC purchased a new position in GE HealthCare Technologies in the 3rd quarter valued at approximately $41,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.